Mohamed A. El-Shahawy

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Sodium Zirconium Cyclosilicate in Hyperkalemia

David Packham, Henrik Rasmussen, Philip T. Lavin et al. · New England Journal of Medicine · 2014 · 482 citations · Full text

Peritoneoscopic versus surgical placement of peritoneal dialysis catheters: A prospective randomized study on outcome

Merit F. Gadallah, Aslam Pervez, Mohamed A. El-Shahawy et al. · American Journal of Kidney Diseases · 1999 · 235 citations

Peritoneal Dialysis Catheters, Laparoscopy, Urology +8

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 206 citations · Full text

Molecular Pharmacology, Hypertension, Resistant Hypertension +9

Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study

Steven Fishbane, Mohamed A. El-Shahawy, Roberto Pecoits‐Filho et al. · Journal of the American Society of Nephrology · 2021 · 167 citations · Full text